-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.
-
Summary
-
ArriVent BioPharma, Inc. quarterly Cash and Cash Equivalents, at Carrying Value history and growth rate from Q4 2023 to Q3 2024.
- ArriVent BioPharma, Inc. Cash and Cash Equivalents, at Carrying Value for the quarter ending September 30, 2024 was $283M.
Cash and Cash Equivalents, at Carrying Value, Quarterly (USD)